BIT Mining Shares Drop As Q2 Revenue Halves On Declining Cryptocurrency Prices

BIT Mining Ltd (NYSE:BTCM) reported a second-quarter FY22 sales decline of 55% year-on-year to $195.5 million. Cryptocurrency price weakness and higher…
  • BIT Mining Ltd (NYSE:BTCM) reported a second-quarter FY22 sales decline of 55% year-on-year to $195.5 million.
  • Cryptocurrency price weakness and higher energy prices have significantly impacted the quarterly revenues.
  • Total hash rate capacity of the company’s online Ethereum mining machines is about 3,536.2GH/s as of August 19, 2022.
  • For 2Q22, BIT Mining produced 4,898 Ethereum from its cryptocurrency mining operations with a revenue of about $11.2 million.
  • Total hash rate capacity of online Bitcoin mining machines is approximately 145.2PH/s as of August 19, 2022.
  • For 2Q22, BIT Mining produced 97 Bitcoins from Bitcoin cryptocurrency mining operations with a revenue of $3.6 million.
  • General and administrative expenses were $5.5 million versus $6.1 million last year.
  • The operating loss for the quarter expanded to $(23.3) million from a loss of $(14.9) million the previous year.
  • The company held $22.7 million in cash and equivalents as of June 30, 2022. It held cryptocurrency assets of $15.4 million.
  • Non-GAAP earnings per ADS for the quarter were $0.09.
  • Price Action: BTCM shares are trading lower by 12.62% at $0.38 on the last check Friday.
  • Photo Via Pixabay
Total
0
Shares
Related Posts
Read More

Nexcella, A Subsidiary Of Immix Biopharma, Presents 42-Patient Interim Data, With 90% Overall Response Rate In Relapsed Or Refractory Multiple Myeloma At NXC-201 Therapeutic Dose From Its Phase 1 Expansion Trial At The 5th European Car T-Cell Meeting

The poster presents data for 42 patients with relapsed or refractory multiple myeloma who were treated with NXC-201 (formerly HBI0101), of which 29 received the therapeutic dose of 800 million CAR+T cells as of the

IMMX